Managerial research on the pharmaceutical supply chain - A critical review and some insights for future directions

Journal of Purchasing and Supply Management

Volumn 20, Issue 1, 2014, Pages 18-40

  Narayana, Sushmita A ^a   Kumar Pati, Rupesh ^a   Vrat, Prem ^b  

^a INDIAN INSTITUTE OF MANAGEMENT KOZHIKODE   (India)

^b THE NORTHCAP UNIVERSITY   (India)

Author keywords

Healthcare; Literature review; Pharmaceutical supply chain

Indexed keywords

EID: 84886857082     PISSN: 14784092     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pursup.2013.09.001     Document Type: Article

References (131)

1. Ahmad N., Awan M.U., Raouf A., Sparks L. Development of a service quality scale for pharmaceutical supply chains. International Journal of Pharmaceutical and Healthcare Marketing 2009, 3(1):26-45.
2. Alshawi S., Saez-Pujol I., Irani Z. Data warehousing in decision support for pharmaceutical R&D supply chain. International Journal of Information Management 2003, 23(3):259-268.
3. Amaro A.C.S., Barbosa-Povoa A.P.F.D. Planning and scheduling of industrial supply chains with reverse flows: a real pharmaceutical case study. Computers and Chemical Engineering 2008, 32:2606-2625.
4. Amaro A.C.S., Barbosa-Povoa A.P.F.D. The effect of uncertainty on the optimal closed-loop supply chain planning under different partnerships structure. Computers and Chemical Engineering 2009, 33:2144-2158.
5. Antai I., Mutshinda C.M. Health status assessment using reverse supply chain data. Management Research Review 2010, 33(2):111-122.
6. Aptel O., Pourjalali H. Improving activities and decreasing costs of logistics in hospitals: a comparison of US and French hospitals. International Journal of Accounting 2001, 36:65-90.
7. Archer N., Bajaj H., Zhang H. Supply management for home healthcare services. INFOR: Information Systems and Operational Research 2008, 46(2):137-145.
8. Arora H., Raghu T.S., Vinze A. Resource allocation for demand surge mitigation during disaster response. Decision Support Systems 2010, 50:304-315.
9. Asamoah D., Abor P., Opare M. An examination of pharmaceutical supply chain for artemisinin-based combination therapies in Ghana. Management Research Review 2011, 34(7):790-809.
10. Awan M.U., Raouf A., Ahmad N., Sparks L. Total quality management in developing countries: a case of pharmaceutical wholesale distribution in Pakistan. International Journal of Pharmaceutical and Healthcare Marketing 2009, 3(4):363-380.
11. Bardey D., Bommier A., Jullien B. Retail price regulation and innovation: Reference pricing in the pharmaceutical industry. Journal of Health Economics 2010, 29:303-316.
12. Beekman A.V., Robinson R.B. Supplier partnerships and the small, high-growth firm: selecting for success. Journal of Small Business Management 2004, 42(1):59-77.
13. Bendavide Y., Boeck H., Philippe R. Redesigning the replenishment process of medical supplies in hospitals with RFID. Business Process Management Journal 2010, 16(6):991-1013.
14. Bhakoo V., Chan C. Collaborative implementation of e-business processes within the health-care supply chain: the Monash pharmacy project. Supply Chain Management: An International Journal 2011, 16(3):184-193.
15. Bossert T.J., Bowser D.M., Amenyah J.K. Is decentralization good for logistics systems? Evidence on essential medicine logistics in Ghana and Guatemala. Health Policy Planning 2007, 22(2):73-82.
16. Boulaksil Y., Fransoo J.C. Implications of outsourcing on operations planning: findings from the pharmaceutical industry. International Journal of Operations and Production Management 2010, 30(10):1059-1079.
17. Breen L., Crawford H. Improving the pharmaceutical supply chain: assessing the reality of e-quality through e-commerce application in hospital pharmacy. International Journal of Quality and Reliability Management 2005, 22(6):572-590.
18. Burgess K., Singh P.J., Koroglu R. Supply chain management: a structured literature review and implications for future research. International Journal of Operations and Production Management 2006, 26(7):703-729.
19. Burns L.R., Wharton School Colleagues The Health Care Value Chain Producers, Purchasers, and Providers 2002, Jossey-Bass, San Francisco, CA.
20. Caridi M., Cavalieri S., Diazzi G., Pirovano C. Assessing the impact of e-Procurement strategies through the use of business process modelling and simulation techniques. Production Planning and Control 2004, 15(7):647-661.
21. Ceccagnoli M., Graham S.J.H., Higgins M.J., Lee J. Productivity and the role of complementary assets in firms' demand for technology innovations. Industrial and Corporate Change 2010, 19(3):839-869.
22. Chahed S., Marcon E., Sahin E., Feillet D., Dallery Y. Exploring new operational research opportunities within the home care context: the chemotherapy at home. Health Care Management Science 2009, 12(2):179-191.
23. Chaudhury R.R., Parameswar R., Gupta U., Sharma S., Tekur U., Bapna J. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy and Planning 2005, 20(2):124-136.
24. Choudhury A.K., Tiwari M.K., Mukhopadhyay S.K. Application of an analytical network process to strategic planning problems of a supply chain cell: Case study of a pharmaceutical firm. Production Planning and Control 2004, 15(1):13-26.
25. Croom S.R., Romano P., Giannakis M. Supply chain management: an analytical framework for critical literature review. European Journal of Purchasing and Supply Management 2000, 6(1):67-83.
26. Cullen A.J., Taylor M. Critical success factors for B2B e-commerce use within the UK NHS pharmaceutical supply chain. International Journal of Operations and Production Management 2009, 29(11):1156-1185.
27. Danas K., Roudsari A., Ketikidis P.H. The applicability of a multi-attribute classification framework in the healthcare industry. Journal of Manufacturing Technology Management 2006, 17(6):772-785.
28. Danese P. The extended VMI for co-ordinating the whole supply network. Journal of Manufacturing Technology Management 2006, 17(7):888-907.
29. Danese P., Romano P., Vinelli A. Sequences of improvement in supply networks: case studies from the pharmaceutical industry. International Journal of Operations and Production Management 2006, 26(11):1199-1222.
30. Datamonitor, 2011. Global Pharmaceuticals. Available From: MarketLine Database (accessed 23.01.12).
31. de Magalhães J.M., de Sousa J.P. Dynamic VRP in pharmaceutical distribution - a case study. Central European Journal of Operations Research 2006, 14(2):177-192.
32. de Vries J., Huijsman R. Supply chain management in health services: an overview. Supply Chain Management: An International Journal 2011, 16(3):159-165.
33. Dekker H.C., Van-Goor A.R. Supply chain management and management accounting: a case study of activity-based costing. International Journal of Logistics Research and Applications 2000, 3(1):41-52.
34. Ellison S.F., Snyder C.M. Countervailing power in wholesale pharmaceuticals. Journal of Industrial Economics 2010, LVIII(1):32-53.
35. Enyinda C.I., Tolliver D. Taking counterfeits out of the pharmaceutical supply chain in Nigeria: leveraging multilayer mitigation approach. Journal of African Business 2009, 10(2):218-234.
36. Ertay T., Kahveci A., Tabanli R.M. An integrated multi-criteria group decision-making approach to efficient supplier selection and clustering using fuzzy preference relations. International Journal of Computer Integrated Manufacturing 2011, 24(12):1152-1167.
37. Fleischhacker A.J., Zhao Y. Planning for demand failure: a dynamic lot size model for clinical trial supply chains. European Journal of Operational Research 2011, 211:496-506.
38. Garattini L., Motterlini N., Cornago D. Prices and distribution margins of in-patent drugs in pharmacy: a comparison in seven European countries. Health Policy 2008, 85(3):305-313.
39. Gebauer H. Robust management policies for positioning pharmacies as healthcare service providers. European Management Journal 2008, 26(3):175-187.
40. Giunipero L.C., Hooker R.E., Joseph-Matthews S., Yoon T.E., Brudvig S. A decade of SCM literature: past, present and future implications. Journal of Supply Chain Management 2008, 44:66-86.
41. Gravier M.J., Farris M.T. An analysis of logistics pedagogical literature: past and future trends in curriculum, content, and pedagogy. International Journal of Logistics Management 2008, 19(2):233-253.
42. Grunow M., Günther H.O., Yang G. Plant co-ordination in pharmaceutics supply networks. OR Spectrum 2003, 25(1):109-141.
43. Gupta A., Pawar K.S., Smart P. New product development in the pharmaceutical and telecommunication industries: a comparative study. International Journal of Production Economics 2007, 106:41-60.
44. Gupta S., Woodside A., Dubelaar C., Bradmore D. Diffusing knowledge-based core competencies for leveraging innovation strategies: modelling outsourcing to knowledge process organizations (KPOs) in pharmaceutical networks. Industrial Marketing Management 2009, 38:219-227.
45. Gupta V., Peters E., Miller T., Kelvin B. Implementing a distribution-network decision-support system at Pfizer/Warner-Lambert. Interfaces 2002, 32(4):28-45.
46. Harwood I.A., Chapman C.B. Risk bartering: what post-M&A integration teams really do. Strategic Change 2009, 18:157-178.
47. Health Action International and World Health Organization, 2009. Medicine Prices, Availability, Affordability and Price Components. Available From: (accessed 16.03.10). http://www.haiweb.org/medicineprices/15072009/Bulletin5final.pdf.
48. Hess A.M., Rothaermel F.T. When are assets complementary? Star scientists, strategic alliances and innovation in the pharmaceutical industry. Strategic Management Journal 2011, 32:895-909.
49. Hilletofth P., Eriksson D. Coordinating new product development with supply chain management. Industrial Management and Data Systems 2011, 111(2):264-281.
50. Hu Q., Schwarz L.B. Controversial role of GPOs in healthcare-product supply chains. Production and Operations Management 2011, 20(1):1-15.
51. Jambulingam T., Kathuria R., Nevin J.R. How fairness garners loyalty in the pharmaceutical supply chain: role of trust in the wholesaler-pharmacy relationship. International Journal of Pharmaceutical and Healthcare Marketing 2009, 3(4):305-322.
52. Jarrett P.G. An analysis of international health care logistics: the benefits and implications of implementing just-in-time systems in the health care industry. Leadership in Health Services 2006, 19(1):i-x.
53. Kanavos P., Vandoros S. Competition in prescription drug markets: is parallel trade the answer?. Managerial and Decision Economics 2010, 31(5):325-338.
54. Kassarjian H.H. Content analysis in consumer research. Journal of Consumer Research 1977, 4(1):8-18.
55. Ketikidis P.H., Kontogeorgis A., Stalidis G., Kaggelides K. Applying e-procurement system in the healthcare: the EPOS paradigm. International Journal of Systems Science 2010, 41(3):281-299.
56. Khurana A. Managing complex production processes. Sloan Management Review 1999, 40(2):85-97.
57. Kirytopoulos K., Leopoulos V., Voulgaridou D. Supplier selection in pharmaceutical industry: an analytic network process approach. Benchmarking: An International Journal 2008, 15(4):494-516.
58. Koulikoff-Souviron M., Harrison A. Evolving HR practices in a strategic intra-firm supply chain. Human Resource Management 2010, 49(5):913-938.
59. Kulp S.L., Randall T., Brandyberry G., Potts K. Using organizational control mechanisms to enhance procurement efficiency: how GlaxoSmithKline improved the effectiveness of e-procurement. Interfaces 2006, 36(3):209-219.
60. Kumar A., Ozdamar L., Ng C.P. Procurement performance measurement system in the health care industry. International Journal of Health Care Quality Assurance 2005, 18(2/3):152-166.
61. Kumar S, Dieveney E., Dieveney A. Reflective practice: Reverse logistic process control measures for the pharmaceutical industry supply chain. International Journal of Productivity and Performance Management 2009, 58(2):188-204.
62. Kumar S., DeGroot R.A., Choe D. Rx for smart hospital purchasing decisions. The impact of package design within US hospital supply chain. International Journal of Physical Distribution and Logistics Management 2008, 38(8):601-615.
63. Kwok S.K., Ting S.L., Tsang A.H.C., Cheung C.F. A counterfeit network analyzer based on RFID and EPC. Industrial Management+Data Systems 2010, 110(7):1018-1037.
64. Lane C., Probert J. The external sourcing of technological knowledge by US pharmaceutical companies: strategic goals and inter-organizational relationships. Industry and Innovation 2007, 14(1):5-25.
65. Lapierre S.D., Ruiz A.B. Scheduling logistic activities to improve hospital supply systems. Computers and Operations Research 2007, 34:624-641.
66. Levis A., Papageorgiou L.G. A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry. Computers and Chemical Engineering 2004, 28:707-725.
67. Linninger A.A., Chakraborty A. Pharmaceutical waste management under uncertainty. Computers and Chemical Engineering 2001, 25:675-681.
68. Lybecker K.M. Keeping it real: anticounterfeiting strategies in the pharmaceutical industry. Managerial and Decision Economics 2008, 29:389-405.
69. Macpherson A., Holt R. Knowledge, learning and small-firm growth: a systematic review of the evidence. Research Policy 2007, 36(2):172-192.
70. Maïga D., Williams-Jones B. Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector. Health Policy 2010, 97(2/3):130-135.
71. Mangan J., Christopher M. Management development and the supply chain manager of the future. International Journal of Logistics Management 2005, 16(2):178-191.
72. McKone-Sweet K.E., Hamilton P., Willis S.B. The ailing healthcare supply chain: a prescription for change. Journal of Supply Chain Management 2005, 41:4-17.
73. Meijboom B., Obel B. Tactical coordination in a multi-location and multi-stage operations structure: a model and a pharmaceutical company case. Omega 2007, 25:258-273.
74. Merkur S., Mossialos E. A pricing policy towards the sourcing of cheaper drugs in Cyprus. Health Policy 2007, 81:368-375.
75. More E., McGrath M. An Australian case in e-health communication and change. Journal of Management Development 2002, 21(8):621-632.
76. Mustaffa N.H., Potter A. Healthcare supply chain management in Malaysia: a case study. Supply Chain Management: An International Journal 2009, 14(3):234-243.
77. Narayana S.A., Pati R.K., Vrat P. Research on management issues in the pharmaceutical industry: a literature review. International Journal of Pharmaceutical and Healthcare Marketing 2012, 6(4):351-375.
78. Nollet J., Beaulieu M. The development of group purchasing: an empirical study in the healthcare sector. Journal of Purchasing and Supply Management 2003, 9:3-10.
79. Nollet J., Beaulieu M. Should an organisation join a purchasing group?. Supply Chain Management: An International Journal 2005, 10(1):11-17.
80. Odagiri H. Transaction costs and capabilities as determinants of the R&D boundaries of the firm: a case study of the ten largest pharmaceutical firms in Japan. Managerial and Decision Economics 2003, 24:187-211.
81. Oduor J., Kamau A., Mathenge E. Evaluating the impact of microfranchising the distribution of anti-malarial drugs in Kenya on malaria mortality and morbidity. Journal of Development Effectiveness 2009, 1(3):353-377.
82. Pan Z.X.T., Pokharel S. Logistics in hospitals: a case study of some Singapore hospitals. Leadership in Health Services 2007, 20(3):195-207.
83. Paich M., Peck C., Valant J. Pharmaceutical market dynamics and strategic planning: a system dynamics perspective. System Dynamics Review 2011, 27(11):47-63.
84. Papageorgiou L.G., Rotstein G.E., Shah N. Strategic supply chain optimization for the pharmaceutical industries. Industrial Engineering and Chemical Research 2001, 40:275-286.
85. Patel A., Norris P., Gauld R., Rades T. Drug quality in South Africa: perceptions of key players involved in medicines distribution. International Journal of Health Care Quality Assurance 2009, 22(5):547-560.
86. Pazirandeh A. Sourcing in global health supply chains for developing countries: literature review and a decision making framework. International Journal of Physical Distribution and Logistics Management 2011, 41(4):364-384.
87. Pedroso M.C., Nakano D. Knowledge and information flows in supply chains: a study on pharmaceutical companies. International Journal of Production Economics 2009, 122:376-384.
88. Pitta D.A., Laric M.V. Value chains in health care. Journal of Consumer Marketing 2004, 21(7):451-464.
89. Pittaway L., Robertson M., Munir K., Denyer D., Neely A. Networking and innovation: a systematic review of the evidence. International Journal of Management Reviews 2004, 5/6(3 and 4):137-168.
90. Ritchie L., Burnes B., Whittle P., Hey R. The benefits of reverse logistics: the case of the Manchester royal infirmary pharmacy. Supply Chain Management: An International Journal 2000, 5(5):226-233.
91. Rivard-Royer H., Landry S., Beaulieu M. Hybrid stockless: a case study: Lessons for health-care supply chain integration. International Journal of Operations and Production Management 2002, 22(4):412-424.
92. Robbins M.J., Jackson S.H. Pediatric vaccine procurement policy: the monopsonist's problem. Omega 2011, 39:589-597.
93. Rodríguez-Monguió R., Rovira J., Seoane-Vázquez E. Analysis of the World Bank's pharmaceutical lending. Health Policy 2007, 81(1):102-116.
94. Rossetti C.L., Handfield R., Dooley K.J. Forces, trends, and decisions in pharmaceutical supply chain management. International Journal of Physical Distribution and Logistics Management 2011, 41(6):601-622.
95. Ruckman K. Externally Sourcing research through acquisition: should it supplement or substitute for internal research?. Industry and Innovation 2008, 15(6):627-645.
96. Russo G., McPake B. Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settings. Health Policy and Planning 2010, 25:70-84.
97. Sabatier V., Mangematin V., Rousselle T. Orchestrating networks in the biopharmaceutical industry: small hub firms can do it. Production Planning and Control 2010, 21(2):218-228.
98. Sarkis J., Zhu Q., Lai K. An organizational theoretic review of green supply chain management literature. International Journal of Production Economics 2011, 130:1-15.
99. Schofield R.A., Breen L. Suppliers, do you know your customers?. International Journal of Quality and Reliability Management 2006, 23(4):390-408.
100. Schwarz B.L., Zhao H. The unexpected impact of information sharing on US pharmaceutical supply chains. Interfaces 2011, 41(4):354-364.
101. Şengün A.E., Wasti S.N. Trust, control, and risk: a test of Das and Teng's conceptual framework for pharmaceutical buyer-supplier relationships. Group and Organization Management 2007, 32(4):430-464.
102. Şengün A.E., Wasti S.N. Revisiting trust and control. International Small Business Journal 2009, 27(1):39-69.
103. Seoane-Vázquez E., Rodríguez-Monguió R. Negotiating antiretroviral drug prices: the experience of the Andean countries. Health Policy and Planning 2007, 22:63-72.
104. Seuring S., Müller M. From a literature review to a conceptual framework for sustainable supply chain management. Journal of Cleaner Production 2008, 16(15):1699-1710.
105. Shah N. Pharmaceutical supply chains: key issues and strategies for optimization. Computers and Chemical Engineering 2004, 28:929-941.
106. Shang J., Yildirim T.P., Tadikamalla P., Mittal V., Brown L.H. Distribution network redesign for marketing competitiveness. Journal of Marketing 2009, 73(2):146-163.
107. Shen Z., Dessouky M., Ordonez F. Perishable inventory management system with a minimum volume constraint. Journal of the Operational Research Society 2011, 62:2063-2082.
108. Sinha K.K., Kohnke E.J. Health care supply chain design: toward linking the development of care globally. Decision Sciences 2010, 40(2):197-212.
109. Spain W.J., Siegel C.F., Ramsey R.P. Selling drugs online: distribution-related legal/regulatory issues. International Marketing Review 2001, 18(4):432-449.
110. Srivastava S.K. Towards estimating cost of quality in supply chains. Total Quality Management and Business Excellence 2008, 19(3):193-208.
111. Stock J.R., Boyer S.L. Developing a consensus definition of supply chain management: a qualitative study. International Journal of Physical Distribution and Logistics Management 2009, 39(8):690-711.
112. Strijbosch L.W.G., Heuts R.M.J., Luijten M.L.J. Cyclical packaging planning at a pharmaceutical company. International Journal of Operations and Production Management 2002, 22(5):549-564.
113. Sundaramoorthy A., Karimi I.A. Planning in pharmaceutical supply chains with outsourcing and new product introductions. Industrial Engineering and Chemical Research 2004, 43:8293-8306.
114. Swaminathan J.M. Decision support for allocating scarce drugs. Interfaces 2003, 33(2):1-11.
115. Swaminathan J.M., Ashe M., Duke K., Maslin L., Wilde L. Distributing scarce drugs for the Medpin program. Interfaces 2004, 34(5):353-358.
116. Talluri S. A buyer-seller game model for selection and negotiation of purchasing bids. European Journal of Operational Research 2002, 143:171-180.
117. Talluri S., Cetin K., Gardner A.J. Integrating demand and supply variability into safety stock evaluations. International Journal of Physical Distribution and Logistics Management 2004, 34(1):62-69.
118. Talluri S., Narasimhan R., Nair A. Vendor performance with supply risk: A chance-constrained DEA approach. International Journal of Production Economics 2006, 100(2):212-222.
119. Thomson Reuters, 2011. Journals in the 2010 JCR. Available From: (accessed 25.12.11). http://thomsonreuters.com/products_services/science/academic/.
120. Tokar T. Behavioural research in logistics and supply chain management. International Journal of Logistics Management 2010, 21(1):89-103.
121. Tranfield D., Denyer D., Smart P. Towards a methodology of developing evidence-informed management knowledge by means of systematic review. British Journal of Management 2003, 14:207-222.
122. van de Vrande V., Vanhaverbeke W., Duysters G. External technology sourcing: the effect of uncertainty on governance mode choice. Journal of Business Venturing 2009, 24:62-80.
123. van Hoek R., Chapman P. From tinkering around the edge to enhancing revenue growth: supply chain-new product development. Supply Chain Management: An International Journal 2006, 11(5):385-389.
124. World Health Organization, 2008. The World Health Report 2008: Primary Health Care Now More Than Ever. Available From: (accessed 25.12.11). http://www.who.int/whr/2008/whr08_en.pdf.
125. World Health Organization, 2010. The World Health Report: Health Systems Financing: the Path to Universal Coverage. Available From: (accessed 25.12.11). http://whqlibdoc.who.int/whr/2010/9789241564021_eng.pdf.
126. Wyld D.C. Genuine medicine?. Competitiveness Review 2008, 18(3):206-216.
127. Wynstra F. What did we do, who did it and did it matter? A review of fifteen volumes of the (European) Journal of Purchasing and Supply Management. Journal of Purchasing and Supply Management 2010, 16:279-292.
128. Yu X., Li C., Shi Y., Yu M. Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy 2010, 97(1):8-15.
129. Zheng J., Bakker E., Knight L., Gilhespy H., Harland C., Walker H. A strategic case for e-adoption in healthcare supply chains. International Journal of Information Management 2006, 26:290-301.
130. Zheng J., Knight L., Harland C., Humby S., James K. An analysis of research into the future of purchasing and supply management. Journal of Purchasing and Supply Management 2007, 13:69-83.
131. Zhuan W., Qinghua Z., bo Y., Wenwen H. 4/R/I/T distribution logistics network 0-1 programming model and application. Computers & Industrial Engineering 2008, 55(2):365-378.